Telomere shortening in intra uterine growth restriction placentas

Early Human Development

Volumn 90, Issue 9, 2014, Pages 465-469

  Biron Shental, Tal ^a,b   Sukenik Halevy, Rivka ^a,b   Sharon, Yudith ^a,c   Laish, Ido ^b   Fejgin, Moshe D ^a,b   Amiel, Aliza ^a,c  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c BAR ILAN UNIVERSITY   (Israel)

Author keywords

HTERT; IUGR; Placenta; Senescence; Telomere; Telomere capture; Trophoblasts

Indexed keywords

MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; ARTICLE; BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HETEROCHROMATIN; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; PATHOGENESIS; PLACENTA; PREGNANCY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; TROPHOBLAST; CASE CONTROL STUDY; GENETICS; HOMEOSTASIS; PATHOLOGY;

CASE-CONTROL STUDIES; FEMALE; FETAL GROWTH RETARDATION; HOMEOSTASIS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERE SHORTENING;

EID: 84905260173     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2014.06.003     Document Type: Article

References (35)

1. ACOG Practice Bulletin No. 134: fetal growth restriction. American College of Obstetricians and Gynecologists. Obstet Gynecol 2013, 121:1122-1133.
2. Ananth C.V., Peltier M.R., Chavez M.R., Kirby R.S., Getahun D., Vintzileos A.M. Recurrence of ischemic placental disease. Obstet Gynecol 2007, 110:128.
3. Chernausek S.D. Update: consequences of abnormal fetal growth. J Clin Endocrinol Metab 2012, 97:689-695.
4. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during aging of human fibroblasts. Nature 1990, 345:458-460.
5. Armanios M. Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Invest 2013, 123:996-1002.
6. Entringer S., Buss C., Wadhwa P.D. Prenatal stress, telomere biology, and fetal programming of health and disease risk. Sci Signal 2012, 5(248):pt12.
7. Davy P., Nagata M., Bullard P., Fogelson N.S., Allsopp R. Fetal growth restriction is associated with accelerated telomere shortening and increased expression of cell senescence markers in the placenta. Placenta 2009, 30:539-542.
8. Biron-Shental T., Sukenik Halevy R., Goldberg-Bittman L., Kidron D., Fejgin M.D., Amiel A. Telomeres are shorter in placental trophoblasts of pregnancies complicated with intrauterine growth restriction (IUGR). Early Hum Dev 2010, 86(7):451-456.
9. Biron-Shental T., Sukenik-Halevy R., Sharon Y., Goldberg-Bittman L., Kidron D., Fejgin M.D., et al. Short telomeres may play a role in placental dysfunction in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2010, 202:381.e17.
10. Biron-Shental T., Kidron D., Sukenik-Halevy R., Goldberg-Bittman L., Sharony R., Fejgin M.D., et al. TERC telomerase subunit gene copy number in placentas from pregnancies complicated with intrauterine growth restriction. Early Hum Dev 2011, 87:73-75.
11. Barker D.J., Osmond C., Kajantie E., Eriksson J.G. Growth and chronic disease: findings in the Helsinki Birth Cohort. Ann Hum Biol 2009, 36(5):445-458.
12. Patti M.E. Intergenerational programming of metabolic disease: evidence from human populations and experimental animal models. Cell Mol Life Sci 2013, 70:1597-1608.
13. Sarr O., Yang K., Regnault T.R. In utero programming of later adiposity: the role of fetal growth restriction. J Pregnancy 2012, 13458.
14. Mason P.J., Perdigones N. Telomere biology and translational research. Transl Res 2013, 162(6):333-342.
15. Narita M., Nũnez S., Heard E., Narita M., Lin A.W., Hearn S.A., et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003, 113:703-716.
16. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003, 426:194-198.
17. Herbig U., Jobling W.A., Chen B.P.C., Chen D.J., Sedivy J.M. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53 and p21CIP1, but not p16INK4a. Mol Cell 2004, 14:501-513.
18. Passos J.F., Saretzki G., von Zglinicki T. DNA damage in telomeres and mitochondria during cellular senescence: is there a connection?. Nucleic Acids Res 2007, 35:7505-7513.
19. Dollberg S., Haklai Z., Mimouni F.B., Gorfein I., Gordon E.S. Birth weight standards in the live-born population in Israel. Isr Med Assoc J 2005, 7(5):311-314.
20. Wyatt S.M., Kraus F.T., Roh C.R., Elchalal U., Nelson D.M., Sadovsky Y. The correlation between sampling site and gene expression in the term human placenta. Placenta 2005, 26:372-379.
21. Amiel A., Goldzak G., Gaber E., Yosef G., Fejgin M.D., Yukla M., et al. Random aneuploidy and telomere capture in chronic lymphocytic leukemia and chronic myeloid leukemia patients. Cancer Genet Cytogenet 2005, 163:12-16.
22. -DDCT method. Methods 2001, 25:402-408.
23. Lossos I.S., Czerwinski D.K., Wechser M.A., Levy R. Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies. Leukemia 2003, 17:789-795.
24. Campisi J., d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007, 8:729-740.
25. Rodier F., Coppe J.P., Patil C.K., Hoeijmakers W.A., Munoz D.P., Raza S.R., et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 2009, 11:973-979.
26. von Zglinicki T., Saretzki G., Ladhoff J., d'Adda di Fagagna F., Jackson S.P. Human cell senescence as a DNA damage response. Mech Ageing Dev 2005, 126:111-117.
27. de Poele R.H., Okorokov A.L., Jardine L., Cummings J., Joel S.P. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 2002, 62:1876-1883.
28. Takai H., Smogorzewska A., De Lange T. DNA damage foci at dysfunctional telomeres. Curr Biol 2003, 13:1549-1556.
29. Narita M., Narita M., Krizhanovsky V., Nuñez S., Chicas A., Hearn S.A., et al. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 2006, 126:503-514.
30. Zhang R., Chen W., Adams P.D. Molecular dissection of formation of senescence associated heterochromatin foci. Mol Cell Biol 2007, 27:2343-2358.
31. Nandakumar J. Cech TR finding the end: recruitment of telomerase to telomeres. Nat Rev Mol Cell Biol 2013, 14(2):69-82.
32. Ballif B.C., Wakui K., Gajecka M., Shaffer L.G. Translocation breakpoint mapping and sequence analysis in three monosomy 1p36 subjects with der(1)t(1;1)(p36;q44) suggest mechanisms for telomere capture in stabilizing de novo terminal rearrangements. Hum Genet 2004, 114:198-206.
33. Slijepcevicp P., Bryant E. Review chromosome healing, telomere capture and mechanisms of radiation-induced chromosome breakage. Int J Radiat Biol 1998, 73(1):1-13. [1].
34. Goldberg-Bittman L., Amiel A., Hadary R., Fejgin M.D., Quitt M., Kitay-Cohen Y. Telomere capture in hepatitis C infection. Cancer Genet Cytogenet 2009, 191:63-66.
35. Draskovic I., Londono Vallejo A. Telomere recombination and alternative telomere lengthening mechanisms. Front Biosci 2013, 18:1-20.